| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/31/2005 | WO2005028451A1 Tetrahydroquinoxalines and their use as m2 acetylcholine receptor agonists |
| 03/31/2005 | WO2005028445A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 03/31/2005 | WO2005028440A1 Novel gamma secretase inhibitors |
| 03/31/2005 | WO2005028436A2 Thalidomide analogs as tnf-alpha modulators |
| 03/31/2005 | WO2005027908A1 Compounds useful as motilin agonists and method |
| 03/31/2005 | WO2005027637A1 Compounds useful as motilin agonists and method |
| 03/31/2005 | WO2005009947A3 Aryl heteroaromatic products, compositions comprising the same and use thereof |
| 03/31/2005 | WO2005007634A8 3-hydroxy-4-oxo-1,2,3-triazines and derivatives thereof for amide and ester bond formation |
| 03/31/2005 | WO2005003064A3 Sulfonamide substituted imidazoquinolines |
| 03/31/2005 | WO2004108133A3 Modulators of vr1 receptor |
| 03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| 03/31/2005 | WO2004089307A3 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
| 03/31/2005 | US20050070720 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/31/2005 | US20050070713 Neurokinin antagonist; therapy for central nervous system disorders; psychological disorders; Parkinson's and Huntington's disease |
| 03/31/2005 | US20050070609 Cyclopentyl modulators of chemokine receptor activity |
| 03/31/2005 | US20050070588 Imidazolyl inhibitors of 15-lipoxygenase |
| 03/31/2005 | US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders |
| 03/31/2005 | US20050070573 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors. |
| 03/31/2005 | US20050070569 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 03/31/2005 | US20050070566 Imidazoquinoline derivatives |
| 03/31/2005 | US20050070563 For example, 3-(RS)-[2-(4-Bromo-benzyl)-1-oxo-2,8-diaza-spiro[4.5]dec-8-ylmethyl]-4-(SR)-phenylpyrrolidine-1-carboxylic acid tert-butyl ester; useful in the prevention or treatment of diseases associated with the modulation of CCR5 chemokine receptor activity; blocking cellular entry of HIV in a subject |
| 03/31/2005 | US20050070555 Aroyl pyridinones |
| 03/31/2005 | US20050070549 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 03/31/2005 | US20050070548 For example, (3R,9aR)-(3,5-bis(trifluoromethyl)phenyl)-[3-(1H-indol-3-ylmethyl)-7-pyridin-3-yl-1,3,4,8,9,9a-hexahydro-pyrido[1,2-a]pyrazin-2-yl]-methanone; useful in the treatment of disorders in which neurokinins which interact with NK1 receptors, e.g. neurokinin-1 (=Substance P) are involved |
| 03/31/2005 | US20050070547 Useful in treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals; for treating conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, overactive bladder, cough, hiccup |
| 03/31/2005 | US20050070546 Tyrosine kinase inhibitors |
| 03/31/2005 | US20050070544 Such as 7-chloro-4-hydroxy-2-[3-(3-chlorophenyl)prop-2-ynyl]-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione; binds NMDA receptor glycine site |
| 03/31/2005 | US20050070542 1-(1-Ethyl-propyl)-5-(2-methoxy-4-trifluoromethoxy-phenyl)-3,6-dimethyl-1H-pyrazolo[3,4-b]pyrazine; modulators of corticotropin releasing factor receptors; for treatment of central nervous system and periphereal disorders (stress, anxiety, depression, cardiovascular disorders, and eating disorders) |
| 03/31/2005 | US20050070525 Such as 3-[2-[4-(11,12-dihydro-6H-benzimidazo[2,1-b][3]benzazepin-6-yl)-2-(phenyl-methyl)-1-piperidinyl]ethyl]-2,10-dimethyl pyrimido[1,2- alpha ]benzimidazol-4(10H)-one |
| 03/31/2005 | US20050070523 For therapy of bacterial infection in a mammal |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | CA2808646A1 Thalidomide analogs |
| 03/31/2005 | CA2539548A1 Novel heterocyclic compounds as hsp90-inhibitors |
| 03/31/2005 | CA2538864A1 Thalidomide analogs as tnf-alpha modulators |
| 03/31/2005 | CA2538789A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acety lcholine receptors |
| 03/31/2005 | CA2538590A1 Novel gamma secretase inhibitors |
| 03/31/2005 | CA2538454A1 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 03/31/2005 | CA2537916A1 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
| 03/31/2005 | CA2537731A1 Compositions useful as inhibitors of protein kinases |
| 03/31/2005 | CA2537325A1 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 03/30/2005 | EP1518855A1 Diaminopyrimidinecarboxa mide derivative |
| 03/30/2005 | EP1517909A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 03/30/2005 | EP1517908A2 Novel benzimidazole derivatives |
| 03/30/2005 | EP1517904A2 Mitotic kinesin inhibitors |
| 03/30/2005 | EP1517895A1 8-(biaryl) quinoline pde4 inhibitors |
| 03/30/2005 | EP1517892A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 03/30/2005 | EP1517684A2 Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| 03/30/2005 | EP1264826B1 Novel imidazoline compounds |
| 03/30/2005 | CN1602308A Thiophene derivatives used as antiviral agent against flavivirus infections |
| 03/30/2005 | CN1602196A Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1600783A Imidazopyridine derivatives |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872834 Phenyl-substituted indoles and indazoles |
| 03/29/2005 | US6872833 Alzheimer's disease; Parkinson's disease; antidepressants |
| 03/29/2005 | US6872830 Synthesized γ-carbolines |
| 03/29/2005 | US6872829 Reacting parent compound with alcohols or acid in presence of cerium ammonium nitrate |
| 03/29/2005 | US6872827 Nitrogen compounds used for modulation of G-protein coupled receptors (GPCRs), as anticarcinogenic agents, analgesics or for prophylaxis of cardiovascular disorders |
| 03/29/2005 | US6872825 Active materials; detectors; libraries |
| 03/29/2005 | US6872746 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/29/2005 | US6872731 Imidazo-pyridine derivatives as ligands for GABA receptors |
| 03/29/2005 | US6872730 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 03/29/2005 | US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 03/29/2005 | US6872721 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dione |
| 03/29/2005 | US6872714 Methods to modulate conditions mediated by the CXCR4 receptor |
| 03/24/2005 | WO2005026171A1 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d¸6,5-d']dipyrimidyne and 10-aza-analogue thereof |
| 03/24/2005 | WO2005026166A1 Physiologically active composition, pharmaceutical composition, substituted 1,2-dihydro[2,7] naphthyridines, method for the production and use thereof |
| 03/24/2005 | WO2005026165A1 Quinolone antibacterial agents |
| 03/24/2005 | WO2005026164A1 Pharmacologically active imidazo[4,5-c]pyridines |
| 03/24/2005 | WO2005026161A1 Antibacterial agents |
| 03/24/2005 | WO2005026154A1 Quinolone antibacterial agents |
| 03/24/2005 | WO2005026147A1 7-(4-substituted 3- cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative |
| 03/24/2005 | WO2005026146A1 Azetidinyl quinolones as antibacterial agents |
| 03/24/2005 | WO2005026145A2 Quinolone antibacterial agents |
| 03/24/2005 | WO2005025681A2 A system for and a method of manufacturing personal golf putters |
| 03/24/2005 | WO2005025579A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/24/2005 | WO2005025507A2 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 03/24/2005 | WO2005025504A2 Modulators of calcitonin and amylin activity |
| 03/24/2005 | WO2005025293A2 Fused ring heterocycles as potassium channel modulators |
| 03/24/2005 | WO2005011597A3 Compounds and compositions as protein kinase inhibitors |
| 03/24/2005 | WO2005009967A3 Quinolinone derivatives as inhibitors of c-fms kinase |
| 03/24/2005 | WO2005007653A3 Substituted tetrahydro-1h-pyrazolo[3,4-c]pyridines, compositions containing same and use |
| 03/24/2005 | WO2005000806A3 Ligands for nicotinic acetylcholine receptors, and methods of making and using them |
| 03/24/2005 | WO2004113335A3 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
| 03/24/2005 | WO2004106293A3 Oxazolyl - and thiazolyl - purine based tricyclic compounds. |
| 03/24/2005 | WO2004096116A3 Diazabicyclononene derivatives |
| 03/24/2005 | WO2004087653A3 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
| 03/24/2005 | WO2004078756A3 Jnk inhibitors |
| 03/24/2005 | WO2004016607A8 Inhibition of phosphoinositide 3-kinase beta |
| 03/24/2005 | US20050065211 Ester derivatives |
| 03/24/2005 | US20050065178 Substituted diazabicycloakane derivatives |
| 03/24/2005 | US20050065174 Novel chain-breaking antioxidants |
| 03/24/2005 | US20050065164 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/24/2005 | US20050065157 Carbazole derivatives and their use as npy5 receptor antagonists |
| 03/24/2005 | US20050065156 Compounds useful as motilin agonists and method |
| 03/24/2005 | US20050064335 Indolestyryl compound for use in recording media and method for fabrication thereof |
| 03/24/2005 | CA2539160A1 Antibacterial agents |
| 03/24/2005 | CA2538420A1 Quinolone antibacterial agents |
| 03/24/2005 | CA2538188A1 Dihydropyridine compounds for treating or preventing metabolic disorders |